$PRSO
Peraso Inc. Stock $prso

$prso Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023024118 Filed on March 29, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$5.033M	$3.887M	$14.87M
YoY Change	47.9%	111.71%	161.81%
Cost Of Revenue	$3.106M	$2.168M	$8.915M
YoY Change	59.45%	10.9%	172.63%
Gross Profit	$1.927M	$1.719M	$5.953M
YoY Change	32.44%	-1544.54%	147.11%
Gross Profit Margin	38.29%	44.22%	40.04%
Selling, General & Admin	$2.242M	$2.170M	$11.11M
YoY Change	-17.12%	-33.44%	58.32%
% of Gross Profit	116.35%	126.24%	186.59%
Research & Development	$3.887M	$4.132M	$19.77M
YoY Change	-29.15%	-47.09%	72.33%
% of Gross Profit	201.71%	240.37%	332.07%
Depreciation & Amortization	$755.0K	$768.0K	$611.0K
YoY Change	-2.71%	-27.89%	-45.25%
% of Gross Profit	39.18%	44.68%	10.26%
Operating Expenses	$5.723M	$6.302M	$38.27M
YoY Change	-30.13%	-43.07%	106.98%
Operating Profit	-$3.796M	-$4.583M	-$32.31M
YoY Change	-43.65%	-59.04%	100.97%
Interest Expense	$658.0K	$14.00K	$16.00K
YoY Change		-99.73%	-99.46%
% of Operating Profit
Other Income/Expense, Net	-$10.00K	-$78.00K	-$89.00K
YoY Change	-44.44%	-86.73%	-302.27%
Pretax Income	-$3.148M	-$14.59M	-$32.40M
YoY Change	-53.39%	120.34%	196.93%
Income Tax
% Of Pretax Income
Net Earnings	-$3.148M	-$14.59M	-$32.40M
YoY Change	-53.39%	120.34%	199.98%
Net Earnings / Revenue	-62.55%	-375.43%	-217.9%
Basic Earnings Per Share	-$0.15		-$1.61
Diluted Earnings Per Share	-$0.15	-$0.71	-$1.61
COMMON SHARES
Basic Shares Outstanding	14.27M shares	12.77M	20.10M shares
Diluted Shares Outstanding	21.56M shares		20.10M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.392M	$2.906M	$2.906M
YoY Change	-85.77%	-80.83%	-80.83%
Cash & Equivalents	$805.0K	$1.828M	$1.828M
Short-Term Investments	$587.0K	$1.078M	$1.078M
Other Short-Term Assets	$742.0K	$1.174M	$1.174M
YoY Change	-44.34%	1.29%	1.29%
Inventory	$4.853M	$5.348M	$5.348M
Prepaid Expenses		$574.0K
Receivables	$2.881M	$3.244M	$3.244M
Other Receivables	$0.00	$41.00K	$41.00K
Total Short-Term Assets	$9.868M	$12.71M	$12.71M
YoY Change	-47.68%	-46.31%	-46.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.078M	$2.225M	$3.372M
YoY Change	-26.1%	-5.28%	13.69%
Goodwill
YoY Change
Intangibles	$5.754M	$6.278M
YoY Change		-24.86%
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$122.0K	$123.0K	$123.0K
YoY Change	56.41%	57.69%	57.69%
Total Long-Term Assets	$8.940M	$9.773M	$9.773M
YoY Change	-61.28%	-59.74%	-59.74%
TOTAL ASSETS
Total Short-Term Assets	$9.868M	$12.71M	$12.71M
Total Long-Term Assets	$8.940M	$9.773M	$9.773M
Total Assets	$18.81M	$22.49M	$22.49M
YoY Change	-55.16%	-53.11%	-53.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.364M	$1.844M	$1.844M
YoY Change	-29.73%	-4.8%	-4.8%
Accrued Expenses	$1.945M	$2.504M	$2.504M
YoY Change	-30.41%	-13.74%	-23.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.553M	$4.680M	$4.680M
YoY Change	-30.29%	-16.34%	-16.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.825M	$2.549M	$2.549M
YoY Change	344.04%	785.07%	785.07%
Total Long-Term Liabilities	$1.825M	$2.549M	$2.549M
YoY Change	344.04%	785.07%	785.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.553M	$4.680M	$4.680M
Total Long-Term Liabilities	$1.825M	$2.549M	$2.549M
Total Liabilities	$5.378M	$7.229M	$7.229M
YoY Change	-2.36%	22.9%	22.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$152.7M	-$149.6M
YoY Change		27.64%
Common Stock	$15.00K	$14.00K
YoY Change		-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.43M	$15.26M	$15.26M
YoY Change
Total Liabilities & Shareholders Equity	$18.81M	$22.49M	$22.49M
YoY Change	-55.16%	-53.11%	-53.11%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$3.148M	-$14.59M	-$32.40M
YoY Change	-53.39%	120.34%	199.98%
Depreciation, Depletion And Amortization	$755.0K	$768.0K	$611.0K
YoY Change	-2.71%	-27.89%	-45.25%
Cash From Operating Activities	-$1.414M	-$2.601M	-$16.02M
YoY Change	-75.37%	-65.06%	33.32%
INVESTING ACTIVITIES
Capital Expenditures	$84.00K	$411.0K	$988.0K
YoY Change	10.53%	-289.4%	-518.64%
Acquisitions
YoY Change
Other Investing Activities	$500.0K	$9.000K	$11.05M
YoY Change	-86.64%	-99.95%	60.93%
Cash From Investing Activities	$416.0K	-$402.0K	$10.04M
YoY Change	-88.59%	-102.22%	51.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.099M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$25.00K	1.979M	$1.918M
YoY Change	177.78%	-119.08%	-79.96%
NET CHANGE
Cash From Operating Activities	-$1.414M	-2.601M	-$16.02M
Cash From Investing Activities	$416.0K	-402.0K	$10.04M
Cash From Financing Activities	-$25.00K	1.979M	$1.918M
Net Change In Cash	-$1.023M	-1.024M	-$4.065M
YoY Change	-51.33%	-509.6%	-197.23%
FREE CASH FLOW
Cash From Operating Activities	-$1.414M	-$2.601M	-$16.02M
Capital Expenditures	$84.00K	$411.0K	$988.0K
Free Cash Flow	-$1.498M	-$3.012M	-$17.01M
YoY Change	-74.24%	-58.33%	44.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-32929
CY2022	dei	Entity Registrant Name EntityRegistrantName	PERASO INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0291941
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2309 Bering Drive
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95131
CY2022	dei	City Area Code CityAreaCode	(408)
CY2022	dei	Local Phone Number LocalPhoneNumber	418-7500
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	PRSO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	22138865	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14269590	shares
CY2022	dei	Auditor Firm AuditorFirmId	572
CY2022	dei	Auditor Name AuditorName	Weinberg & Company
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1828000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5893000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1078000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	9267000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3244000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2436000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5348000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	3824000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	41000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1099000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	600000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	574000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1159000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12713000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23678000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	2928000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2225000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2349000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1147000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	617000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6278000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8355000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	9946000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	123000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	78000	usd
CY2022Q4	us-gaap	Assets Assets	22486000	usd
CY2021Q4	us-gaap	Assets Assets	47951000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1844000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1937000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1817000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2903000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	332000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	375000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	687000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	379000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4680000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5594000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	470000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	288000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2079000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7229000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	5882000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12284000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12284000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12284000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12284000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9107000	shares
CY2021Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9295000	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164865000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	159256000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149597000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-117199000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15257000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	42069000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22486000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47951000	usd
CY2022	prso	Net Revenueof Product NetRevenueofProduct	14199000	usd
CY2021	prso	Net Revenueof Product NetRevenueofProduct	4906000	usd
CY2022	prso	Net Revenueof Royalty And Other NetRevenueofRoyaltyAndOther	669000	usd
CY2021	prso	Net Revenueof Royalty And Other NetRevenueofRoyaltyAndOther	773000	usd
CY2022	us-gaap	Revenues Revenues	14868000	usd
CY2021	us-gaap	Revenues Revenues	5679000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	8915000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	3270000	usd
CY2022	us-gaap	Gross Profit GrossProfit	5953000	usd
CY2021	us-gaap	Gross Profit GrossProfit	2409000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19768000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11471000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11108000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7016000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2557000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9946000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	38265000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	18487000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-32312000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-16078000	usd
CY2022	us-gaap	Interest Expense InterestExpense	16000	usd
CY2021	us-gaap	Interest Expense InterestExpense	2979000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1595000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8102000	usd
CY2022	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	1576000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-89000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	44000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10911000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-25000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32423000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10911000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.86
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20100000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5869000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3921000	usd
CY2021	prso	Issuance Of Common Stock Under Stock Plans Net IssuanceOfCommonStockUnderStockPlansNet	-37000	usd
CY2021	prso	Stock Issued During Period Value Settlement Of Warrants To Common Stock StockIssuedDuringPeriodValueSettlementOfWarrantsToCommonStock	1208000	usd
CY2021	prso	Stock Issued During Period Value Conversion Of Convertible Debentures To Common Stock StockIssuedDuringPeriodValueConversionOfConvertibleDebenturesToCommonStock	13545000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	37627000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4484000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10911000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	42069000	usd
CY2022	prso	Issuance Of Common Stock Under Stock Plans Net IssuanceOfCommonStockUnderStockPlansNet	119000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2099000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2099000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-25000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5730000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32398000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15257000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-32398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10911000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3057000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1116000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5730000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4484000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1595000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8102000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1576000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9946000	usd
CY2022	prso	Accrued Interest On Investments AccruedInterestOnInvestments	9000	usd
CY2021	prso	Accrued Interest On Investments AccruedInterestOnInvestments	721000	usd
CY2022	prso	Interest Portion Of Financing Lease Repayment InterestPortionOfFinancingLeaseRepayment	16000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2091000	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	89000	usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	27000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	808000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	848000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1525000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1418000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	59000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-560000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1160000	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	484000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-94000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	804000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	578000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	252000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-542000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-236000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1128000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-72000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16020000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12016000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	988000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	165000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11534000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	400000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	488000	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	6464000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10037000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6628000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2099000	usd
CY2022	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	61000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	785000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1262000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	9055000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	120000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1918000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9569000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4065000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4181000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5893000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1712000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1828000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5893000	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	3673000	usd
CY2022	prso	Recognition Of Rightofuse Assets And Lease Liabilities RecognitionOfRightofuseAssetsAndLeaseLiabilities	1003000	usd
CY2022	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-26000	usd
CY2021Q4	prso	Fair Value Of New Warrant Liability Issued Recognized As Debt Discount FairValueOfNewWarrantLiabilityIssuedRecognizedAsDebtDiscount	-2604000	usd
CY2021Q4	prso	Settlement Of Loan Facility Against Tax Receivables SettlementOfLoanFacilityAgainstTaxReceivables	-1097000	usd
CY2021Q4	prso	Effect Of Business Combination EffectOfBusinessCombination	-37627000	usd
CY2021	prso	Settlement Of Warrants To Common Stock SettlementOfWarrantsToCommonStock	1208000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	13545000	usd
CY2021Q3	prso	Agreement Amount AgreementAmount	2864555	usd
CY2022Q4	us-gaap	Net Investment In Lease Allowance For Credit Loss NetInvestmentInLeaseAllowanceForCreditLoss	32400000	usd
CY2021Q4	us-gaap	Net Investment In Lease Allowance For Credit Loss NetInvestmentInLeaseAllowanceForCreditLoss	10900000	usd
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	149600000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	61000000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	3824000	usd
CY2022Q4	prso	Prepaid Inventory And Production Cost PrepaidInventoryAndProductionCost	186000	usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period. Material estimates may include assumptions made in determining reserves for uncollectible receivables, inventory write-downs, impairment of long-term assets, purchase price allocations, valuation allowance on deferred tax assets, accruals for potential liabilities and assumptions made in valuing equity instruments. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2022Q4	prso	Allowance For Doubtful Accounts As Percentage Of Invoice Value For Problematic Customer Balances Maximum AllowanceForDoubtfulAccountsAsPercentageOfInvoiceValueForProblematicCustomerBalancesMaximum	1	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	183000000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	420000000	usd
CY2021Q4	prso	Scientific Research And Experimental Development Cost Tax Credit Eligible Percentage ScientificResearchAndExperimentalDevelopmentCostTaxCreditEligiblePercentage	0.15	pure
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8468000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2190000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6278000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8447000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-92000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8355000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	28000000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2099000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2099000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2011000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	28000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	31000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6278000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10670000	usd
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-19977000	usd
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	9900000	usd
CY2022	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically 60 days or less.
CY2022	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1100000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	243000000	usd
CY2022	prso	Revenue Practical Expedient Period In Which Customer Payments Due From Invoice Date RevenuePracticalExpedientPeriodInWhichCustomerPaymentsDueFromInvoiceDate	P60Y
CY2021	prso	Payroll Subsidies PayrollSubsidies	1120475000	usd
CY2021	prso	Rent Subsidies RentSubsidies	199235000	usd
CY2021	us-gaap	Acquisition Costs AcquisitionCosts	1628000	usd
CY2021	prso	Business Acquisitions Pro Forma Adjusted Net Income Loss BusinessAcquisitionsProFormaAdjustedNetIncomeLoss	-18349000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9330000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3595000	shares
CY2021Q4	prso	Conversion Ratio Of Common Stock2 ConversionRatioOfCommonStock2	0.045239122387267	pure
CY2022	prso	Ownership Percentage OwnershipPercentage	0.61	pure
CY2022	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	pure
CY2022	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30	pure
CY2022Q4	us-gaap	Debt Instrument Convertible Liquidation Preference Per Share DebtInstrumentConvertibleLiquidationPreferencePerShare	8.57
CY2022Q4	prso	Percentage Of Number Of Exchangeable Shares Issued Remain Outstanding PercentageOfNumberOfExchangeableSharesIssuedRemainOutstanding	0.10	pure
CY2022	prso	Percentage Of Voting Securities PercentageOfVotingSecurities	0.50	pure
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1	usd
CY2022Q4	prso	Common Stock Shares Issued And Outstanding CommonStockSharesIssuedAndOutstanding	21569158	shares
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	19064000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	2558000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	833000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	8282000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	9946000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities	3056000	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	37627000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	prso	Corporate Notes And Commercial Paper CorporateNotesAndCommercialPaper	1078000	usd
CY2022Q4	prso	Warrant Liability WarrantLiability	2079000	usd
CY2021Q4	prso	Corporate Notes And Commercial Paper CorporateNotesAndCommercialPaper	12195000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2931000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2906000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	18104000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	16000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18088000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1279000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	879000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2595000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2170000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1474000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	775000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	5348000	usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	prso	Prepaid Inventory And Production Cost PrepaidInventoryAndProductionCost	671000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	47000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	44000	usd
CY2022Q4	prso	Prepaid Softwares PrepaidSoftwares	173000	usd
CY2021Q4	prso	Prepaid Softwares PrepaidSoftwares	277000	usd
CY2022Q4	prso	Other Prepaid Expenses OtherPrepaidExpenses	168000	usd
CY2021Q4	prso	Other Prepaid Expenses OtherPrepaidExpenses	167000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	574000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1159000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4630000	usd
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	8944000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	342000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	2200000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	93000	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	323000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	555000	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	354000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5620000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11821000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	3395000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	9472000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2225000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2349000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	6380000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6227000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	153000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	153000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	469000	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	506000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	514000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1252000	usd
CY2021Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	340000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	14000	usd
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	190000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	233000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	330000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	39000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	29000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	451000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	353000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1817000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2903000	usd
CY2022Q4	us-gaap	Incentive To Lessee IncentiveToLessee	220000000	usd
CY2022	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	1000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.08	pure
CY2022Q1	prso	Lease Liability LeaseLiability	274000000	usd
CY2022Q4	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	124000000	usd
CY2022Q4	prso	Lease Liability LeaseLiability	117000000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	826000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	321000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1147000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	834000	usd
CY2022Q4	prso	Finance Lease Liabilities FinanceLeaseLiabilities	323000	usd
CY2022Q4	prso	Operating And Financing Lease Liabilities OperatingAndFinancingLeaseLiabilities	1157000	usd
CY2022Q4	prso	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	688000	usd
CY2022Q4	prso	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	263000	usd
CY2022Q4	prso	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	164000	usd
CY2022Q4	prso	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	107000	usd
CY2022Q4	prso	Operating Leases Future Minimum Payment Due In Five Years OperatingLeasesFutureMinimumPaymentDueInFiveYears	81000	usd
CY2022Q4	prso	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	1303000	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	146000	usd
CY2022Q4	prso	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	1157000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	704000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	248000	usd
CY2022Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	700000	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	600000	usd
CY2022	prso	Warrant Term WarrantTerm	P3Y
CY2022	prso	Defined Contribution Plan Required Age Of Employees To Be Eligible For Participation In Plan DefinedContributionPlanRequiredAgeOfEmployeesToBeEligibleForParticipationInPlan	P21Y
CY2022	prso	Defined Contribution Plan Maximum Contributions By Plan Participants Percentage DefinedContributionPlanMaximumContributionsByPlanParticipantsPercentage	0.15	pure
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	14868000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5679000	usd
CY2022	us-gaap	Production Costs ProductionCosts	14199000	usd
CY2021	us-gaap	Production Costs ProductionCosts	4906000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2022Q4	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	0.10	pure
CY2022	prso	Accounts Receiveble Percentage AccountsReceiveblePercentage	0.79	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	183000	usd
CY2021	prso	Accounts Receiveble Percentage AccountsReceiveblePercentage	0.96	pure
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1693000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4300000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9017000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5409000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	344000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	198000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	611000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	917000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2682000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2691000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	965000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6655000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6675000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20274000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15890000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20274000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15890000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4400000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2000000	usd
CY2022	prso	Equity Method Ownership Percentage EquityMethodOwnershipPercentage	0.50	pure
CY2022	prso	Percentage Of Limitation On Federal And State Net Operating Loss Carryforwards PercentageOfLimitationOnFederalAndStateNetOperatingLossCarryforwards	0.89	pure
CY2022	prso	Percentage Of Limitation On Federal Tax Credit Carryforwards PercentageOfLimitationOnFederalTaxCreditCarryforwards	0.88	pure
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	8500000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6804000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1503000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-38000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-131000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1033000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	60000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	60000	usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	2089000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3774000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	7700000	usd
CY2022	prso	Share Based Compensation Arrangement By Share Based Payment Award Term Of Plan ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfPlan	P2Y
CY2022	prso	Percentage Of Voting Power PercentageOfVotingPower	0.10	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	356000	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1053000	shares
CY2020Q4	prso	Weighted Average Exercise Prices Balance WeightedAverageExercisePricesBalance	2.54
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	3107000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	30000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	409000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	409000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	20000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.72
CY2021	prso	Number Of Shares Options Cancelled And Returned To The Plans NumberOfSharesOptionsCancelledAndReturnedToThePlans	-42000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.72
CY2021	prso	Share Based Compensation Arrangement By Share Based Payment Award Options Effect Of Business Combination ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEffectOfBusinessCombination	158000	shares
CY2021	prso	Weighted Average Exercise Prices Effect Of Business Combinationin Dollars WeightedAverageExercisePricesEffectOfBusinessCombinationinDollars	10.35
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3024000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1558000	shares
CY2021Q4	prso	Weighted Average Exercise Prices Balance WeightedAverageExercisePricesBalance	3.49
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	1732000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	264000	shares
CY2022	prso	Number Of Shares Options Cancelled NumberOfSharesOptionsCancelled	-59000	shares
CY2022	prso	Weighted Average Exercise Prices Options Cancelled WeightedAverageExercisePricesOptionsCancelled	6.27
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1556000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1499000	shares
CY2022Q4	prso	Weighted Average Exercise Prices Balance WeightedAverageExercisePricesBalance	3.32
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3675	shares
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2079000	usd
CY2021Q1	us-gaap	Shares Issued SharesIssued	375000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	30000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	10000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.21
CY2021	prso	Number Of Shares Effect Of Business Combination NumberOfSharesEffectOfBusinessCombination	68000	shares
CY2021	prso	Weighted Average Grant Date Fair Value Effect Of Business Combination WeightedAverageGrantDateFairValueEffectOfBusinessCombination	4.21
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	88000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.5
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1732000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.1
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	589000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.29
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	174000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.19
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1057000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.06
CY2022Q4	us-gaap	Shares Issued SharesIssued	1300000	shares
CY2022Q4	prso	Purchase Price Per Share PurchasePricePerShare	1
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.01
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2100000	usd
CY2022	prso	Percentage Of Fair Value Volatility PercentageOfFairValueVolatility	1	pure
CY2022	prso	Fair Value Of Warrant Granted FairValueOfWarrantGranted	3700000	usd
CY2022	prso	Fair Value Of Warrant Liability FairValueOfWarrantLiability	2100000	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	2099000000	usd
CY2022Q4	us-gaap	Financing Receivable Loan In Process FinancingReceivableLoanInProcess	1576000000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y4M24D
CY2022	prso	Risk Free Interest Rate Percentage RiskFreeInterestRatePercentage	0.04	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.14	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2022	prso	Recognition Of Warrant Liabilities RecognitionOfWarrantLiabilities	3675	shares
CY2022	prso	Recognition Of Warrants Liabilities RecognitionOfWarrantsLiabilities	3674000	usd
CY2022	prso	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	-1595000	usd
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	133000	shares
CY2021Q4	us-gaap	Shares Issued SharesIssued	508000	shares
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	184558	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	235132	cad
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3000000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2100000	cad
CY2021	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	700000	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	200000	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	162000000	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	208000000	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	3062500000	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable	437500000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2600000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	prso	Preferred Stock Value One PreferredStockValueOne		usd
CY2021Q4	prso	Preferred Stock Value One PreferredStockValueOne		usd
CY2021Q4	prso	Exchangeable Common Stock Value ExchangeableCommonStockValue		usd
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost		usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	prso	Interest Portion Of Financing Lease Repayment InterestPortionOfFinancingLeaseRepayment		usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities		usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2021	prso	Recognition Of Rightofuse Assets And Lease Liabilities RecognitionOfRightofuseAssetsAndLeaseLiabilities		usd
CY2021	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss		usd
CY2022Q4	prso	Fair Value Of New Warrant Liability Issued Recognized As Debt Discount FairValueOfNewWarrantLiabilityIssuedRecognizedAsDebtDiscount		usd
CY2022Q4	prso	Settlement Of Loan Facility Against Tax Receivables SettlementOfLoanFacilityAgainstTaxReceivables		usd
CY2022Q4	prso	Effect Of Business Combination EffectOfBusinessCombination		usd
CY2022	prso	Settlement Of Warrants To Common Stock SettlementOfWarrantsToCommonStock		usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
CY2022Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
CY2021	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized		shares
CY2021	prso	Weighted Average Exercise Prices Additional Shares Authorized Under The Plan WeightedAverageExercisePricesAdditionalSharesAuthorizedUnderThePlan
CY2021	prso	Number Of Shares Rs Us Grantedin Dollars Per Share NumberOfSharesRSUsGrantedinDollarsPerShare		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021	prso	Shares Available For Grant Options Cancelled And Returned To The Plans SharesAvailableForGrantOptionsCancelledAndReturnedToThePlans		shares
CY2021	prso	Shares Available For Grant Effect Of Business Combinationin SharesAvailableForGrantEffectOfBusinessCombinationin		shares
CY2022	prso	Number Of Shares Rs Us Grantedin Dollars Per Share NumberOfSharesRSUsGrantedinDollarsPerShare		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
CY2022	prso	Number Of Shares Rs Us Cancelled And Returned To The Plansin Dollars Per Share NumberOfSharesRSUsCancelledAndReturnedToThePlansinDollarsPerShare		shares
CY2022	prso	Weighted Average Exercise Prices Rs Us Cancelled And Returned To The Plansin Dollars Per Share WeightedAverageExercisePricesRSUsCancelledAndReturnedToThePlansinDollarsPerShare
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2022	prso	Number Of Sharesrecast Change In Fair Value Of Warrants NumberOfSharesrecastChangeInFairValueOfWarrants		shares
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000890394

Files In Submission

Name	View Source	Status
0001213900-23-024118-index-headers.html	Edgar Link	pending
0001213900-23-024118-index.html	Edgar Link	pending
0001213900-23-024118.txt	Edgar Link	pending
0001213900-23-024118-xbrl.zip	Edgar Link	pending
ex10-17_001.jpg	Edgar Link	pending
ex10-18_001.jpg	Edgar Link	pending
ex10-19_001.jpg	Edgar Link	pending
f10k2022ex10-17_perasoinc.htm	Edgar Link	pending
f10k2022ex10-18_perasoinc.htm	Edgar Link	pending
f10k2022ex10-19_perasoinc.htm	Edgar Link	pending
f10k2022ex21-1_perasoinc.htm	Edgar Link	pending
f10k2022ex23-1_perasoinc.htm	Edgar Link	pending
f10k2022ex31-1_perasoinc.htm	Edgar Link	pending
f10k2022ex31-2_perasoinc.htm	Edgar Link	pending
f10k2022ex32_perasoinc.htm	Edgar Link	pending
f10k2022ex4-6_perasoinc.htm	Edgar Link	pending
f10k2022_perasoinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prso-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
prso-20221231_cal.xml	Edgar Link	unprocessable
prso-20221231_def.xml	Edgar Link	unprocessable
prso-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_perasoinc_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
prso-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRSO
Peraso Inc. Stock $prso

2023 Q1 Form 10-K Financial Statement

#000121390023024118 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSO Peraso Inc. Stock $prso

2023 Q1 Form 10-K Financial Statement

#000121390023024118 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSO
Peraso Inc. Stock $prso